Spots Global Cancer Trial Database for childhood solid tumor
Every month we try and update this database with for childhood solid tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| PRecISion Medicine for Children With Cancer | NCT03336931 | Childhood Cance... Childhood Solid... Childhood Brain... Childhood Leuke... Refractory Canc... Relapsed Cancer | Molecular profi... | - 21 Years | Sydney Children's Hospitals Network | |
| French Childhood Cancer Survivor Study | NCT01620372 | Childhood Solid... | - 18 Years | Institut National de la Santé Et de la Recherche Médicale, France | ||
| Precision Medicine for Every Child With Cancer | NCT05504772 | Childhood Cance... Childhood Solid... Childhood Brain... Childhood Leuke... Refractory Canc... Relapsed Cancer | Whole Genome Se... RNA seq DNA Methylation Targeted Panel ... High Throughput... Patient Derived... Liquid Biopsy | 0 Years - 25 Years | Australian & New Zealand Children's Haematology/Oncology Group | |
| Sirolimus With Cyclophosphamide and Topotecan for Pediatric/Adolescent Relapsed and Refractory Solid Tumors | NCT01670175 | Malignant Solid... Childhood Solid... | Sirolimus, Cycl... | - 25 Years | University of California, San Francisco | |
| Haploidentical Stem Cell Transplantation and IL-15 NK Cell Infusion for Paediatric Refractory Solid Tumours | NCT01337544 | Childhood Solid... | HAPLOIDENTICAL ... | 6 Months - 22 Years | Hospital Infantil Universitario Niño Jesús, Madrid, Spain | |
| Comparing the Impact of Cancer on Quality of Life Between Survivors of Childhood Solid Tumors and Leukemia | NCT03430752 | Childhood Solid... | questionnaires | 6 Years - 19 Years | The University of Hong Kong | |
| Haploidentical Stem Cell Transplantation and IL-15 NK Cell Infusion for Paediatric Refractory Solid Tumours | NCT01337544 | Childhood Solid... | HAPLOIDENTICAL ... | 6 Months - 22 Years | Hospital Infantil Universitario Niño Jesús, Madrid, Spain | |
| Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) | NCT02624388 | Lymphoma Childhood Lymph... Solid Tumor Childhood Solid... Neuroblastoma Ewing Sarcoma Hodgkin Lymphom... Non-Hodgkin Lym... Rhabdomyosarcom... Soft Tissue Sar... Medulloblastoma Germ Cell Tumor Wilms Tumor Brain Neoplasms Medulloblastoma... Neuroectodermal... | Genistein Placebo | 1 Year - 21 Years | University of Virginia | |
| French Childhood Cancer Survivor Study | NCT01620372 | Childhood Solid... | - 18 Years | Institut National de la Santé Et de la Recherche Médicale, France | ||
| Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid Tumors | NCT03585465 | Childhood Solid... | Vinblastine Cyclophosphamid... Capecitabine Nivolumab | 0 Years - 18 Years | Centre Oscar Lambret | |
| Precision Medicine for Every Child With Cancer | NCT05504772 | Childhood Cance... Childhood Solid... Childhood Brain... Childhood Leuke... Refractory Canc... Relapsed Cancer | Whole Genome Se... RNA seq DNA Methylation Targeted Panel ... High Throughput... Patient Derived... Liquid Biopsy | 0 Years - 25 Years | Australian & New Zealand Children's Haematology/Oncology Group | |
| A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors | NCT04671901 | Solid Tumor Solid Tumor, Ch... Solid Carcinoma | Romiplostim | 1 Year - 21 Years | Memorial Sloan Kettering Cancer Center | |
| Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer | NCT06208657 | Childhood Cance... Childhood Solid... Childhood Brain... Recurrent Cance... Refractory Canc... | Paxalisib, Irin... Pimasertib | 0 Years - 21 Years | Australian & New Zealand Children's Haematology/Oncology Group | |
| Sirolimus With Cyclophosphamide and Topotecan for Pediatric/Adolescent Relapsed and Refractory Solid Tumors | NCT01670175 | Malignant Solid... Childhood Solid... | Sirolimus, Cycl... | - 25 Years | University of California, San Francisco |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
